HIGHLIGHTS
- who: Yao Jiang from the Department of Pharmacology, Institute of Basic Medical Sciences, Chinese Medical College, Beijing, China have published the Article: DTX-P7, a peptide-drug conjugate, is highly effective for non-small cell lung cancer, in the Journal: (JOURNAL)
SUMMARY
As shown in Fig 1a, b, intraperitoneal administration of 20 mg/kg DTX-P7 (equivalent to DTX dose calculated as DTX) reduced tumor growth by 93.2% compared with control mice, whereas the tumor growth inhibition of DTX was only 35.9%. The data demonstrated a widespread impact of DTX-P7 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.